Bank of New York Mellon’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,250,350
| Closed | -$65.6M | – | 4309 |
|
|
2020
Q3 | $65.6M | Sell |
1,250,350
-77,539
| -6% | -$3.21M | 0.02% | 757 |
|
|
2020
Q2 | $44.2M | Buy |
1,327,889
+51,649
| +4% | +$1.64M | 0.01% | 955 |
|
|
2020
Q1 | $34.7M | Buy |
1,276,240
+70,029
| +6% | +$1.95M | 0.01% | 953 |
|
|
2019
Q4 | $23.8M | Buy |
1,206,211
+77,313
| +7% | +$1.24M | 0.01% | 1464 |
|
|
2019
Q3 | $14.6M | Buy |
1,128,898
+589
| +0.1% | +$7.11K | ﹤0.01% | 1718 |
|
|
2019
Q2 | $14M | Buy |
1,128,309
+12,314
| +1% | +$163K | ﹤0.01% | 1772 |
|
|
2019
Q1 | $16.2M | Buy |
1,115,995
+69,744
| +7% | +$891K | ﹤0.01% | 1681 |
|
|
2018
Q4 | $11.6M | Buy |
1,046,251
+152,220
| +17% | +$2.12M | ﹤0.01% | 1815 |
|
|
2018
Q3 | $23.5M | Buy |
894,031
+27,708
| +3% | +$749K | 0.01% | 1523 |
|
|
2018
Q2 | $17.7M | Sell |
866,323
-33,442
| -4% | -$718K | ﹤0.01% | 1673 |
|
|
2018
Q1 | $16.3M | Sell |
899,765
-952
| -0.1% | -$15.9K | ﹤0.01% | 1709 |
|
|
2017
Q4 | $12.6M | Buy |
900,717
+2,933
| +0.3% | +$39.6K | ﹤0.01% | 1875 |
|
|
2017
Q3 | $16.6M | Buy |
897,784
+56,748
| +7% | +$949K | ﹤0.01% | 1678 |
|
|
2017
Q2 | $14.2M | Buy |
841,036
+47,301
| +6% | +$720K | ﹤0.01% | 1764 |
|
|
2017
Q1 | $10.6M | Buy |
793,735
+32,760
| +4% | +$513K | ﹤0.01% | 1932 |
|
|
2016
Q4 | $11.5M | Buy |
760,975
+53,170
| +8% | +$702K | ﹤0.01% | 1884 |
|
|
2016
Q3 | $8.27M | Buy |
707,805
+1,205
| +0.2% | +$14.2K | ﹤0.01% | 1965 |
|
|
2016
Q2 | $7.63M | Sell |
706,600
-24,075
| -3% | -$248K | ﹤0.01% | 1992 |
|
|
2016
Q1 | $6.75M | Sell |
730,675
-1,416
| -0.2% | -$15.2K | ﹤0.01% | 2030 |
|
|
2015
Q4 | $10.9M | Buy |
732,091
+3,073
| +0.4% | +$51.4K | ﹤0.01% | 1794 |
|
|
2015
Q3 | $12M | Buy |
729,018
+85,903
| +13% | +$1.76M | ﹤0.01% | 1755 |
|
|
2015
Q2 | $14.7M | Buy |
643,115
+156,225
| +32% | +$3.11M | ﹤0.01% | 1713 |
|
|
2015
Q1 | $7.4M | Buy |
486,890
+16,995
| +4% | +$221K | ﹤0.01% | 2097 |
|
|
2014
Q4 | $5.66M | Sell |
469,895
-12,564
| -3% | -$144K | ﹤0.01% | 2254 |
|
|
2014
Q3 | $5.47M | Buy |
482,459
+23,656
| +5% | +$270K | ﹤0.01% | 2257 |
|
|
2014
Q2 | $5.54M | Sell |
458,803
-70,521
| -13% | -$833K | ﹤0.01% | 2274 |
|
|
2014
Q1 | $6.17M | Sell |
529,324
-9,408
| -2% | -$159K | ﹤0.01% | 2203 |
|
|
2013
Q4 | $9.52M | Sell |
538,732
-7,170
| -1% | -$120K | ﹤0.01% | 1911 |
|
|
2013
Q3 | $7.86M | Buy |
545,902
+13,798
| +3% | +$211K | ﹤0.01% | 1954 |
|
|
2013
Q2 | $8.01M | Buy |
+532,104
| New | +$7.02M | ﹤0.01% | 1909 |
|
Bank of New York Mellon's MNTA Position: Q4 2020 in Review
Bank of New York Mellon sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,250,350 shares — an estimated $65.6M sold.
Bank of New York Mellon first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $65.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Bank of New York Mellon reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Bank of New York Mellon sold 1,250,350 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $65.6M.
- Bank of New York Mellon first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Bank of New York Mellon's Momenta Pharmaceuticals, Inc. position peaked at $65.6M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Bank of New York Mellon's 13F filing for Q4 2020, filed 9 Feb 2021.